About Zinc finger protein 880
Zinc finger protein 880 (ZNF880) is a protein
from Homo sapiens identified by UniProt accession
Q6PDB4, 577 residues long.
MolForge cross-references it against 0 known binders and
17 disease associations.
Target properties
| Protein name | Zinc finger protein 880 |
| UniProt accession | Q6PDB4 |
| Gene | ZNF880 |
| Organism | Homo sapiens |
| Length | 577 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (17)
Diseases linked to this target (Open Targets).
- colorectal carcinoma · score 0.08
- neoplasm · score 0.05
- cancer · score 0.05
- reading · score 0.02
- Acute hepatic failure · score 0.01
- atrial fibrillation · score 0.01
- Adams-Oliver syndrome · score 0.00
- head and neck squamous cell carcinoma · score 0.00
- acute lymphoblastic leukemia · score 0.00
- endometrial carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6PDB4-F1 | alphafold | PREDICTED | 69.34 | — |
Amino-acid sequence (577 residues)
MLRRGHLAFR DVAIEFPQEE WKCLDPAQRT LYREVMVENY RNLVFLGICL PDLSVISMLE QRRDPRNLQS EVKIANNPGG RECIKGVNAE SSSKLGSNAG NKSLKNQLGL TFQLHLSELQ LFQAERNISG CKHVEKPINN SLVSPLQKIY SSVKSHILNK YRNDFDDSPF LPQEQKAQIR EKPCECNEHG KAFRVSSRLA NNQVIHTADN PYKCNECDKV FSNSSNLVQH QRIHTGEKPY KCHECGKLFN RISLLARHQR IHTGEKPYKC HECGKVFTQN SHLANHHRIH TGEKPYKCNE CGKVFNRNAH LARHQKIHSG EKPYKCKECG KAFSGGSGLT AHLVIHTGEK LYKCNKCGKV FNRNAHLTRH QRIHTGEKPY ECKECGKVFR HKFCLTNHHR MHTGEQPYKC NECGKAFRDC SGLTAHLLIH TGEKPYKCKE CAKVFRHRLS LSNHQRFHTG EKPYRCDECG KDFTRNSNLA NHHRIHTGEK PYKCSECHKV FSHNSHLARH RQIHTGEKSY KCNECGKVFS HKLYLKKHER IHTGEKPYRC HECGKDFTRN SNLANHHRIH TGEKPYR
Explore Zinc finger protein 880 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets